What Is CJC-1295 with DAC / Ipamorelin?

CJC-1295 with DAC / Ipamorelin is a research peptide combination blending CJC-1295 with Drug Affinity Complex (a long-acting GHRH analog) and Ipamorelin (a selective ghrelin mimetic GHS).

* CJC-1295 with DAC: Modified 30-amino acid GHRH analog with Nε-maleimidopropionyl-Lys at position 30 for albumin binding, sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-(Nε-maleimidopropionyl-Lys)-NH₂

* Ipamorelin: Pentapeptide with sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ Molecular weights approximate: CJC-1295 with DAC ~3,647 daltons, Ipamorelin ~712 daltons (DAC extends systemic exposure; acetate salts enhance solubility/stability) How It Works Mechanism: Synergistic GH axis stimulation — CJC-1295 with DAC provides sustained GHRH receptor activation for prolonged GH/IGF-1 elevation; Ipamorelin offers selective, pulsatile GH release via GHS-R1a without elevating cortisol/ACTH/prolactin Binding Domains: CJC-1295 preserves modified GHRH pharmacophore with DAC for extended action; Ipamorelin retains full ghrelin mimetic structure Key Features:

- Complementary secretagogues (GHRH analog + selective GHS)

- Acetate salts for lyophilized stability

- Extended (CJC) + short (Ipamorelin) half-lives promote sustained + pulsatile GH patterns

- SubQ flexibility

Binding Strategy:

* CJC-1295 N-terminal Tyr-D-Ala → GHRH-R pocket

* DAC-Lys → albumin binding for slow release

* Ipamorelin Aib-His → GHS-R1a activation

* Central D-amino acids → enzymatic resistance

* Pituitary-selective synergy

* Dual cAMP/PKA + PLC/Ca²⁺ cascade amplification

Primary Mechanisms

1. Sustained + Pulsatile GH Release

* CJC-1295: Prolonged GHRH-R activation (GH 2-10× for 6+ days)

* Ipamorelin: Rapid GH pulses (peak ~40 min, selective)

* Combined: Enhanced overall GH/IGF-1 output

* Mimics physiologic patterns with amplification

2. IGF-1 Axis Amplification

* Hepatic IGF-1 upregulation (sustained 0.5-3× for days-weeks)

* Maintains negative feedback (physiologic)

* Enhances anabolic signaling (PI3K/Akt/mTOR)

3. Pituitary Priming & Selectivity

* Prevents desensitization via complementary pathways

* Ipamorelin avoids cortisol/ACTH/prolactin rise

* Restores youthful GH pulse characteristics

4. Neuroendocrine Modulation

* Hypothalamic-pituitary axis enhancement

* Supports sleep-stage GH secretion

* Minimal off-target endocrine disruption

5. GH Network

* Combo activates cascade: Pituitary:

* GHRH-R + GHS-R1a Liver:

* IGF1, ALS Systemic:

* GHBP, collagen genes Feedback:

* SOCS2, IGFBP3

Preclinical Effects Growth & Anabolism

* GH/IGF Models (animals/humans):

* Lean mass trends upward

* Muscle hypertrophy supported

* Bone density potential increase

Aging Reversal

* Aged Models:

* GH/IGF-1 restoration toward youth levels

* Body composition improvement

* Recovery enhanced

Metabolic Health

* Obesity Models:

* Fat reduction trends

* Insulin sensitivity generally preserved

* Energy expenditure ↑

Neurological

* Cognitive Models:

* Potential BDNF support

* Sleep quality trends improved

Cardiac & Immune

* Heart Function: Contractility supported

* Immune: Overall function trends restored

CJC-1295 with DAC / Ipamorelin at Vitality Labz Our Commitment to Excellence At Vitality Labz, we recognize CJC-1295 with DAC / Ipamorelin's importance in advancing peptide use. Our CJC-1295 with DAC / Ipamorelin offering represents professional-grade quality:

* 99%+ Purity: Verified by third-party testing

* Professional-Grade Quality: Suitable for serious scientific investigation

* Proper Storage: Shipped and stored under optimal conditions

* Documentation: Complete certificates of analysis provided

* Educational Support: Access to professional resources and information

Conclusion

CJC-1295 with DAC / Ipamorelin represents an exciting frontier in peptides. As studies continue to explore this combination's mechanisms and applications, it offers professionals valuable tools for scientific investigation into synergistic GH axis modulation, anabolic support, and metabolic effects. At Vitality Labz, we are committed to supporting this research with premium-quality CJC-1295 with DAC / Ipamorelin that meets the highest standards of purity and reliability. The future of this peptide blend use is being written today, and every quality study contributes to our growing knowledge.

Important Legal and Safety Information FDA Approval and Regulatory Status The professional compounds discussed in this article have not been evaluated by the Food and Drug Administration (FDA). CJC-1295 with DAC and Ipamorelin are not approved by the FDA for human consumption, therapeutic use, or as a dietary supplement. (Note: CJC-1295 investigated in phase I/II trials for GH deficiency/HIV lipodystrophy but development discontinued due to safety concerns; Ipamorelin studied in phase II for postoperative ileus but discontinued; combination not formally approved for clinical applications.) Medical Disclaimer This information is not intended to diagnose, treat, cure, or prevent any disease. The content provided is for educational and informational purposes only and should not be construed as medical advice. Always consult with qualified healthcare professionals before making any health-related decisions. Professional Use Only CJC-1295 with DAC / Ipamorelin mentioned in this article is intended for professional purposes only. It is not intended for human or animal consumption. Quality and Purity Statements While Vitality Labz provides third-party testing for purity and quality assurance, individual results in professional applications may vary. Proper storage, handling, and usage protocols must be followed to maintain compound integrity. We make no guarantees regarding use outcomes or applications.